Sarepta Therapeutics (SRPT) Amortization - Intangibles (2017 - 2026)
Sarepta Therapeutics' quarterly Amortization - Intangibles came in at $691000.0 in Q1 2026, up 14.98% year-on-year from $601000.0 in Q1 2025, and up 2.07% quarter-over-quarter from $677000.0 in Q4 2025.
Sarepta Therapeutics has reported Amortization - Intangibles for 10 years, with the latest figure at $691000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles rose 14.98% year-over-year to $691000.0; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 12.77% YoY), and the FY2025 full-year result was $2.6 million, up 9.02% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $691000.0, up from $677000.0 in the prior quarter.
- The five-year high for Amortization - Intangibles was $763000.0 in Q4 2023, with the low at $178000.0 in Q1 2022.
- Average Amortization - Intangibles over 5 years is $470058.8, with a median of $601000.0 recorded in 2024.
- Year-over-year, Amortization - Intangibles surged 326.26% in 2023 and decreased 21.23% in 2024.
- Tracing SRPT's Amortization - Intangibles over 5 years: stood at $179000.0 in 2022, then soared by 326.26% to $763000.0 in 2023, then declined by 21.23% to $601000.0 in 2024, then advanced by 12.65% to $677000.0 in 2025, then gained by 2.07% to $691000.0 in 2026.
- The last three Amortization - Intangibles figures came in at $691000.0 (Q1 2026), $677000.0 (Q4 2025), and $677000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 691,000.00 |
| Dec 31, 2025 | 677,000.00 |
| Sep 30, 2025 | 677,000.00 |
| Jun 30, 2025 | 667,000.00 |
| Mar 31, 2025 | 601,000.00 |
| Dec 31, 2024 | 601,000.00 |
| Sep 30, 2024 | 602,000.00 |
| Jun 30, 2024 | 601,000.00 |
| Mar 31, 2024 | 601,000.00 |
| Dec 31, 2023 | 763,000.00 |
| Sep 30, 2023 | 439,000.00 |
| Jun 30, 2023 | 179,000.00 |
| Mar 31, 2023 | 178,000.00 |
| Dec 31, 2022 | 179,000.00 |
| Sep 30, 2022 | 178,000.00 |
| Jun 30, 2022 | 179,000.00 |
| Mar 31, 2022 | 178,000.00 |
| Dec 31, 2021 | 179,000.00 |
| Sep 30, 2021 | 178,000.00 |
| Jun 30, 2021 | 179,000.00 |
| Mar 31, 2021 | 170,000.00 |
| Dec 31, 2020 | 165,000.00 |
| Sep 30, 2020 | 166,000.00 |
| Jun 30, 2020 | 165,000.00 |
| Mar 31, 2020 | 166,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 30, 2019 | 216,000.00 |
| Jun 30, 2019 | 217,000.00 |
| Mar 31, 2019 | 216,000.00 |
| Dec 31, 2018 | 216,000.00 |
| Sep 30, 2018 | 216,000.00 |
| Jun 30, 2018 | 217,000.00 |
| Mar 31, 2018 | 216,000.00 |
| Dec 31, 2017 | 216,000.00 |
| Sep 30, 2017 | 780,000.00 |
| Jun 30, 2017 | 29,000.00 |
| Mar 31, 2017 | 28,000.00 |